search
Back to results

Contribution of Acupuncture on Pain Related to the Screening of Premature Retinopathy (ROP) by Digital Camera (ELAROP)

Primary Purpose

Laser Stimulation

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Laser stimulation
Sponsored by
Assistance Publique - Hôpitaux de Paris
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Laser Stimulation

Eligibility Criteria

23 Weeks - 31 Weeks (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Premature from 23+0 to 30sa+6d regardless of birth weight with 1st FO for ROP screening;
  • Premature birth weights < 1250g with a 1st FO for ROP screening;
  • Informed consent of the holder(s) of parental authority;
  • Child benefiting from a social security system

Exclusion Criteria:

  • Analgesic or sedative drug treatment (benzodiazepines, morphine and related) within 48 hours of the examination.
  • Known chromosomal abnormality

Sites / Locations

  • Hôpital Robert Debré

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Laser Stimulation

Placebo

Arm Description

laser pen acupuncture projecting an infrared beam with a wavelength of 905nm bilaterally for 30 seconds on each point.

The placebo group will have an application of the pen according to the same extinguished laser criteria.

Outcomes

Primary Outcome Measures

score at PIPP (premature infant pain profile) ≥ 10
Measurement of pain or discomfort defined by a PIPP score ≥ 10

Secondary Outcome Measures

pain and discomfort
Assess pain and discomfort (score FANS). The FANS score is a validated hetero-rating scale for assessing acute newborn pain when the face is difficult to analyse. On the 0 to 10 side, the absence of pain is defined by a score < 3
heart rate variability
assessment of heart rate variability (NIPE score)

Full Information

First Posted
November 13, 2018
Last Updated
April 28, 2020
Sponsor
Assistance Publique - Hôpitaux de Paris
search

1. Study Identification

Unique Protocol Identification Number
NCT03757871
Brief Title
Contribution of Acupuncture on Pain Related to the Screening of Premature Retinopathy (ROP) by Digital Camera
Acronym
ELAROP
Official Title
Contribution of Acupuncture on Pain Related to the Screening of Premature Retinopathy (ROP) by Digital Camera
Study Type
Interventional

2. Study Status

Record Verification Date
March 2020
Overall Recruitment Status
Completed
Study Start Date
March 26, 2019 (Actual)
Primary Completion Date
March 1, 2020 (Actual)
Study Completion Date
March 1, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Pain management in premature infants is essential because they are exposed to repeated minor painful procedures such as screening for premature retinopathy (ROP). Acupuncture has shown its analgesic effectiveness in many studies. Laser acupuncture is a simple, fast, side-effect-free method, but no study exists on the contribution of acupuncture in the management of pain caused by the examination of the fundus in addition to conventional therapies (suction, Glucose G30%, anaesthetic eye drops) which are not sufficiently effective. Hypothesis: Laser acupuncture is a medical device that would reduce the pain and discomfort of premature newborns when examining the fundus with a digital camera.
Detailed Description
Randomized, single-centre, randomized, double-blind, randomized, controlled clinical trial in two parallel groups, acupuncture versus placebo as an add-on to the usual analgesic strategy (Glucose G 30%/suction and administration of a drop of anesthetic eye drops). The main objective is to evaluate the contribution of acupuncture versus placebo as an add-on to the G30% glucose solution 2 minutes before the examination associated with the instillation of a drop of oxybuprocaine administered 1 minute before the start of the examination on pain assessed at the first eye fundus (FO) by the score premature infant pain profile (PIPP) measured before the start of the examination (baseline) and on 30 seconds after the examination of both eyes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Laser Stimulation

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
50 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Laser Stimulation
Arm Type
Experimental
Arm Description
laser pen acupuncture projecting an infrared beam with a wavelength of 905nm bilaterally for 30 seconds on each point.
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
The placebo group will have an application of the pen according to the same extinguished laser criteria.
Intervention Type
Device
Intervention Name(s)
Laser stimulation
Intervention Description
an acupuncture or placebo session will be performed 30 minutes before the fundus examination. This session will last 5 minutes.
Primary Outcome Measure Information:
Title
score at PIPP (premature infant pain profile) ≥ 10
Description
Measurement of pain or discomfort defined by a PIPP score ≥ 10
Time Frame
24 hours
Secondary Outcome Measure Information:
Title
pain and discomfort
Description
Assess pain and discomfort (score FANS). The FANS score is a validated hetero-rating scale for assessing acute newborn pain when the face is difficult to analyse. On the 0 to 10 side, the absence of pain is defined by a score < 3
Time Frame
24 hours
Title
heart rate variability
Description
assessment of heart rate variability (NIPE score)
Time Frame
24 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
23 Weeks
Maximum Age & Unit of Time
31 Weeks
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Premature from 23+0 to 30sa+6d regardless of birth weight with 1st FO for ROP screening; Premature birth weights < 1250g with a 1st FO for ROP screening; Informed consent of the holder(s) of parental authority; Child benefiting from a social security system Exclusion Criteria: Analgesic or sedative drug treatment (benzodiazepines, morphine and related) within 48 hours of the examination. Known chromosomal abnormality
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Farnoux Caroline, PHD
Organizational Affiliation
APHP
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Biran Valerie, PHD
Organizational Affiliation
APHP
Official's Role
Study Chair
Facility Information:
Facility Name
Hôpital Robert Debré
City
Paris
ZIP/Postal Code
75019
Country
France

12. IPD Sharing Statement

Learn more about this trial

Contribution of Acupuncture on Pain Related to the Screening of Premature Retinopathy (ROP) by Digital Camera

We'll reach out to this number within 24 hrs